4-Hydroxy Pralatrexate | CAS 1548618-61-6 - Request Quote
4-Hydroxy Pralatrexate
| SZ CAT No: | SZ-P084002 |
| CAS No | 1548618-61-6 |
| Mol.F. | C23H22N6O6 |
| Mol.Wt. | 478.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
4-Hydroxy Pralatrexate is chemically (4-(1-(2-amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamic acid. 4-Hydroxy Pralatrexate is supplied with detailed characterization data compliant with regulatory guideline. 4-Hydroxy Pralatrexate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pralatrexate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1548618-61-6
Purchase 1548618-61-6
Order 1548618-61-6
Enquire 1548618-61-6
price of 1548618-61-6
1548618-61-6 Supplier
1548618-61-6 Manufacturer
1548618-61-6 Exporter
buy high quality 4-Hydroxy Pralatrexate
Purchase 4-Hydroxy Pralatrexate
4-Hydroxy Pralatrexate suppliers
4-Hydroxy Pralatrexate manufacturers
4-Hydroxy Pralatrexate price
Order 4-Hydroxy Pralatrexate
Enquire 4-Hydroxy Pralatrexate
4-Hydroxy Pralatrexate cost
4-Hydroxy Pralatrexate Supplier
4-Hydroxy Pralatrexate Distributor
4-Hydroxy Pralatrexate for Method Validation
Pralatrexate Reference Standard
4-Hydroxy Pralatrexate for ANDA Filing
4-Hydroxy Pralatrexate for Forced Degradation Studies
4-Hydroxy Pralatrexate Identification Standards
4-Hydroxy Pralatrexate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.